SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
+3.37%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$277M
AUM Growth
+$277M
(-4.1%)
Cap. Flow
-$58.1M
Cap. Flow
% of AUM
-20.99%
Top 10 Holdings %
Top 10 Hldgs %
46.92%
Holding
254
New
38
Increased
26
Reduced
76
Closed
42
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$8.46M |
| 2 |
CELG
Celgene Corp
CELG
|
$3.94M |
| 3 |
United Therapeutics
UTHR
|
$3.32M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$2.76M |
| 5 |
Tenet Healthcare
THC
|
$2.56M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$15.2M |
| 2 |
VXZ
iPath S&P 500 VIX Mid-Term Futures ETN due 1/30/2019
VXZ
|
$6.65M |
| 3 |
Abbott
ABT
|
$6.42M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$4.21M |
| 5 |
SCON
Superconductor Technologies Inc.
SCON
|
$3.87M |
Sector Composition
| 1 | Healthcare | 87.44% |
| 2 | Consumer Staples | 0.39% |
| 3 | Technology | 0.24% |
| 4 | Industrials | 0.1% |
| 5 | Materials | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cidara Therapeutics
CDTX
$1.58B
| $2.18M | 0.08% |
190,358
+170,081
| +839% | +$1.95M |
|
|
ALPN
27
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $2.18M | 0.08% |
267,650
-373,842
| -58% | -$3.04M |
|
|
ARAV
28
DELISTED
Aravive, Inc. Common Stock
ARAV
| $2.14M | 0.08% |
+174,968
| New | +$2.14M |
|
|
FWP
29
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $2.08M | 0.08% |
99,053
-3,082
| -3% | -$64.7K |
|
30
Iovance Biotherapeutics
IOVA
$792M
| $2.03M | 0.08% |
246,342
-120,900
| -33% | -$995K |
|
|
IRD
31
Opus Genetics, Inc. Common Stock
IRD
$74.9M
| $1.99M | 0.07% |
9,464,849
+393,681
| +4% | +$82.7K |
|
32
Actinium Pharmaceuticals
ATNM
$53.7M
| $1.87M | 0.07% |
+1,382,629
| New | +$1.87M |
|
|
FOMX
33
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $1.87M | 0.07% |
201,564
-52,142
| -21% | -$483K |
|
|
BDSI
34
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $1.86M | 0.07% |
689,900
-95,899
| -12% | -$259K |
|
|
BPTH
35
DELISTED
Bio-Path Holdings Inc
BPTH
| $1.84M | 0.07% |
1,314,692
-1,673,603
| -56% | -$2.34M |
|
36
Editas Medicine
EDIT
$225M
| $1.82M | 0.07% |
+135,000
| New | +$1.82M |
|
37
Intellia Therapeutics
NTLA
$1.25B
| $1.78M | 0.07% |
+104,841
| New | +$1.78M |
|
|
ZGNX
38
DELISTED
Zogenix, Inc.
ZGNX
| $1.72M | 0.06% |
150,000
-139,200
| -48% | -$1.59M |
|
|
AIM
39
AIM ImmunoTech Inc.
AIM
$6.56M
| $1.69M | 0.06% |
+1,351,850
| New | +$1.69M |
|
40
Adverum Biotechnologies
ADVM
$67.1M
| $1.66M | 0.06% |
402,603
-377,323
| -48% | -$1.55M |
|
|
EDAP
41
EDAP TMS
EDAP
$98.7M
| $1.58M | 0.06% |
545,918
-301,307
| -36% | -$874K |
|
|
CYTXW
42
DELISTED
Cytori Therapeutics Inc Warrant
CYTXW
| $1.55M | 0.06% |
895,017
-109,048
| -11% | -$188K |
|
|
CORV
43
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $1.52M | 0.06% |
+484,505
| New | +$1.52M |
|
|
WGBS
44
DELISTED
WaferGen Bio-systems, Inc.
WGBS
| $1.52M | 0.06% |
1,578,616
-288,634
| -15% | -$278K |
|
45
FibroGen
FGEN
$48.5M
| $1.5M | 0.06% |
72,669
-24,605
| -25% | -$509K |
|
46
VistaGen Therapeutics
VTGN
$110M
| $1.45M | 0.05% |
349,096
-274,221
| -44% | -$1.14M |
|
|
ONCS
47
DELISTED
OncoSec Medical Incorporated
ONCS
| $1.43M | 0.05% |
834,004
+225,952
| +37% | +$386K |
|
|
RXDX
48
DELISTED
Ignyta, Inc.
RXDX
| $1.42M | 0.05% |
225,900
+900
| +0.4% | +$5.66K |
|
|
XYLO
49
DELISTED
Xylo Technologies
XYLO
| $1.37M | 0.05% |
+1,042,813
| New | +$1.37M |
|
50
Rocket Pharmaceuticals
RCKT
$355M
| $1.37M | 0.05% |
144,002
+37,548
| +35% | +$356K |
|